Their value comes from shared physiological, anatomical, and behavioral features with humans, which allow researchers to examine selected aspects of human biology under controlled conditions. These similarities do not make the findings identical to human outcomes, but they provide an experimental bridge for studying disease processes and evaluating responses before further investigation in people.
Each assay type captures a different level of response. Molecular measurements can examine biological changes, physiological assays can assess changes in body function, and behavioral assays can reveal effects on observable performance or activity. Combining these outcomes helps researchers connect mechanisms with functional consequences rather than relying on a single measurement.
Researchers can study a defined condition, administer an intervention, and measure outcomes within a controlled laboratory setting. This control makes it easier to relate observed changes to the condition or treatment being examined, an advantage when clinical studies cannot isolate biological processes as precisely. The resulting evidence can clarify mechanisms and treatment responses.
A study may begin by selecting or establishing a rat condition that represents the biological question, followed by administration of an intervention when treatment is being evaluated. Researchers then collect molecular, physiological, or behavioral measurements and compare the resulting responses. This workflow connects the experimental condition with measurable outcomes relevant to disease or therapy.
Applications span disease-mechanism research, drug pharmacology, toxicology, surgery, and rehabilitation. The same general platform can therefore support different questions, such as how a condition develops, how an intervention acts, whether exposure produces harmful effects, or how a procedure or rehabilitation approach changes measured outcomes. Its use depends on the research question and selected assays.
Results can clarify biological processes, characterize responses to interventions, and identify evidence relevant to therapeutic development. Researchers may use these findings to judge whether a treatment warrants further evaluation in human research. Rat studies therefore contribute to decision-making before clinical investigation, while their role remains to inform, rather than replace, human studies.